Literature DB >> 25053414

Cysteines introduced into extracellular loops 1 and 4 of human P-glycoprotein that are close only in the open conformation spontaneously form a disulfide bond that inhibits drug efflux and ATPase activity.

Tip W Loo1, David M Clarke2.   

Abstract

P-glycoprotein (P-gp) is an ATP-binding cassette drug pump that protects us from toxic compounds and confers multidrug resistance. The protein is organized into two halves. The halves contain a transmembrane domain (TMD) with six transmembrane segments and a nucleotide-binding domain (NBD). The drug- and ATP-binding sites reside at the TMD1/TMD2 and NBD1/NBD2 interfaces, respectively. ATP-dependent drug efflux involves changes between the open inward-facing (NBDs apart, extracellular loops (ECLs) close together) and the closed outward-facing (NBDs close together, ECLs apart) conformations. It is controversial, however, whether the open conformation only exists transiently in intact cells because of the presence of high levels of ATP. To test for the presence of an open conformation in intact cells, reporter cysteines were placed in extracellular loops 1 (A80C, N half) and 4 (R741C, C half). The rationale was that cysteines A80C/R741C would only come close enough to form a disulfide bond in an open conformation (6.9 Å apart) because they are separated widely (30.4 Å apart) in the closed conformation. It was observed that the mutant A80C/R741C cross-linked spontaneously (>90%) when expressed in cells. In contrast to previous reports showing that trapping P-gp in a closed conformation highly activated ATPase activity, here we show that A80C/R741C cross-linking inhibited ATPase activity and drug efflux. Both activities were restored when the cross-linked mutant was treated with a thiol-reducing agent. The results show that an open conformation can be readily detected in cells and that cross-linking of cysteines placed in ECLs 1 and 4 inhibits activity.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ABC Transporter; Drug Resistance; Membrane Enzyme; Membrane Protein; Protein Cross-linking

Mesh:

Substances:

Year:  2014        PMID: 25053414      PMCID: PMC4155644          DOI: 10.1074/jbc.M114.583021

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  ABC efflux pump-based resistance to chemotherapy drugs.

Authors:  Paul D W Eckford; Frances J Sharom
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 2.  Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.

Authors:  David S Miller; Björn Bauer; Anika M S Hartz
Journal:  Pharmacol Rev       Date:  2008-06-17       Impact factor: 25.468

3.  Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP.

Authors:  Zuben E Sauna; In-Wha Kim; Krishnamachary Nandigama; Stephan Kopp; Peter Chiba; Suresh V Ambudkar
Journal:  Biochemistry       Date:  2007-11-08       Impact factor: 3.162

4.  Structure of a multidrug transporter.

Authors:  Michael M Gottesman; Suresh V Ambudkar; Di Xia
Journal:  Nat Biotechnol       Date:  2009-06       Impact factor: 54.908

5.  Processing mutations disrupt interactions between the nucleotide binding and transmembrane domains of P-glycoprotein and the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2008-08-16       Impact factor: 5.157

6.  Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.

Authors:  Michael K Gannon; Jason J Holt; Stephanie M Bennett; Bryan R Wetzel; Tip W Loo; M Claire Bartlett; David M Clarke; Geri A Sawada; J William Higgins; Gregory Tombline; Thomas J Raub; Michael R Detty
Journal:  J Med Chem       Date:  2009-05-28       Impact factor: 7.446

7.  Nucleotide-induced structural changes in P-glycoprotein observed by electron microscopy.

Authors:  Jyh-Yeuan Lee; Ina L Urbatsch; Alan E Senior; Stephan Wilkens
Journal:  J Biol Chem       Date:  2007-12-19       Impact factor: 5.157

Review 8.  Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1.

Authors:  Daniel A P Gutmann; Andrew Ward; Ina L Urbatsch; Geoffrey Chang; Hendrik W van Veen
Journal:  Trends Biochem Sci       Date:  2009-10-12       Impact factor: 13.807

9.  Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2009-07-06       Impact factor: 5.157

10.  Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  Biochemistry       Date:  2007-07-18       Impact factor: 3.162

View more
  3 in total

Review 1.  Thiol-Disulfide Exchange Reactions in the Mammalian Extracellular Environment.

Authors:  Michael C Yi; Chaitan Khosla
Journal:  Annu Rev Chem Biomol Eng       Date:  2016-03-17       Impact factor: 11.059

2.  Identification of an Extracellular Gate for the Proton-coupled Folate Transporter (PCFT-SLC46A1) by Cysteine Cross-linking.

Authors:  Rongbao Zhao; Mitra Najmi; Andras Fiser; I David Goldman
Journal:  J Biol Chem       Date:  2016-02-16       Impact factor: 5.157

3.  Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2015-10-26       Impact factor: 5.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.